Wilson’s disease drug market size is expected to reach USD 848.2 million by 2031, according to AMR

Allied Market Research

Allied Market Research

Rising prevalence of Wilson’s diseases and advancements in R&D activities for drug development are driving the growth of the global Wilson’s disease drugs market. By drug type, penicillamine segment held the largest share in 2021. By region, on the other hand, Asia-Pacific would cite the fastest CAGR of 5.5% during the forecast period.

Portland, OR, Dec. 12 2022 (GLOBE NEWSWIRE) — According to the report published by Allied Market Research, the Drugs for Wilson’s disease Market the size was estimated to reach $595.2 million in 2021 and is projected to reach $848.2 million by 2031, registering a CAGR of 3.6% from 2022 to 2031. The report provides a detailed analysis of major pockets of investment, winning strategies, drivers and opportunities, market size and estimates, competitive landscape and changing market trends. Market research is a useful source of information for early adopters, new entrants, investors and shareholders in developing strategies for the future and strengthening their position in the market.

Download a free sample report: https://www.alliedmarketresearch.com/request-sample/15824

Report coverage and details:

Report cover


Forecast period


Year of reference


Market size in 2021

$595.2 million

Market size in 2031

$848.2 million



Number of pages in the report


Segments Covered

Drug type, distribution channel and region.


Increase in the prevalence of Wilson’s disease

Progress in R&D activities for drug development


Lack of knowledge and diagnostic facilities associated with the treatment of Wilson’s disease

High treatment cost due to certain complications


High government investment for drug development and increased healthcare spending

Covid-19 scenario-

  • The outbreak of the pandemic has acted as a significant constraint on the Wilson’s disease drug market, particularly in 2020, as it has reduced the movement of people, goods and services around the world, disrupted supply chains procurement, restricted sales operations, marketing efforts and customer support, and hindered the shipment and delivery of products to customers. The market saw a decline in sales of their revenue, especially during the initial period.

  • However, as the global situation began to recover, the market for Wilson’s disease drugs also got back on track.

The global Wilson disease drug market is analyzed by drug type, distribution channel and region. The report contains an exhaustive analysis of the segments and their sub-segments using tabular and graphical representation. Investors and market participants can benefit from the breakdown and devise schemes based on the most revenue-generating and fastest-growing segments shown in the report.

By drug type, the penicillamine segment held nearly two-fifths of the global Wilson’s disease drug market revenue in 2021 and is expected to dominate by 2031. The trientine segment, on the other hand, would manifest the highest CAGR faster by 4.0% throughout the forecast period. The zinc segment is also evaluated as part of the study.

Purchase order : https://www.alliedmarketresearch.com/purchase-enquiry/15824

By distribution channel, the retail pharmacy segment held almost three-fifths of the global Wilson’s disease drug market share in 2021 and is expected to dominate by 2031. The online pharmacy segment, however, would cite the Fastest CAGR of 5.6% throughout the forecast. period. The hospital pharmacy segment is also analyzed in the report.

Based on region, the North America market generated more than two-fifths of the global Wilson’s disease drug market share in 2021 and is expected to retain the lion’s share by 2031. The Asia-Pacific region, on the other hand, would manifest the fastest CAGR of 5.5% during the forecast period. Other provinces analyzed in the report include LAMEA and Europe.

The major market players analyzed in the global Wilson’s disease drugs market report are Pfizer Inc., ANI Pharmaceuticals, Inc., APOTEX, Bausch Health Companies Inc., Lupine Limited, Vivet Therapeutics, Breckenridge Pharmaceutical, Inc. , Dr. Reddy’s Laboratories Ltd, NAVINTA LLC and Teva Pharmaceutical Industries Ltd.

These market players have adopted several strategies including partnership, expansion, collaboration, joint ventures and others to showcase their prowess in the industry. The report is helpful in formulating the business performance and developments of key players.

Reports on trends in the healthcare industry (book now with 10% discount):

Hepatitis C Testing Market by technique (immunoassay, PCR, other techniques), by test (antibody test, genotype tests, viral load test), by end user (hospital and diagnostic laboratory, blood banks, other end users): analysis of Global Opportunities and Industry Forecast, 2021 -2031

Medical Tapes Market By Product (Cloth Tapes, Paper Tapes, Plastic Tapes, Others), By Application (Surgery, Wound Dressing, Safe IV Lines, Others), By End User (Hospitals, Ambulatory Surgical Centers, Clinics, Others): Analysis of Global Opportunities and Industry Forecast, 2021-2031

Niacinamide Market By Type (Powder, Liquid, Others), By Application (Pharmaceutical, Cosmetic, Human Nutrition), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Pharmacies, and Retail Pharmacies): Global Opportunities Analysis and Industry Forecast , market 2021-2031

sharps container market by type (patient room containers, phlebotomy containers, multipurpose containers), by container size (1-2 gallons, 2-4 gallons, 4-8 gallons), by use (single-use containers, reusable containers): Global Opportunity Analysis and Industry Forecast, 2021-2031

Neonatal Intensive Care Market By Product (Warmers, Incubators, Monitors, Breathing Devices, Phototherapy Equipment, Others), By Application (Neonatal Hypothermia & Low Birth Weight, Jaundice, Others), By End User (Hospitals, Maternities, Neonatal & Pediatric Hospital ): Global Opportunity Analysis and Industry Forecast, 2021-2031

About Us

Allied Market Research (AMR) is a full-service market research and business consulting division of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global corporations as well as small and medium enterprises with unparalleled quality of “Market research reportsand “Business Intelligence Solutions”. AMR has a focused vision to provide business insights and advice to help its clients make strategic business decisions and achieve sustainable growth in their respective market area.

We maintain professional relationships with various companies which helps us to extract market data which helps us to generate accurate research data tables and confirm the utmost accuracy of our market predictions. Allied Market Research CEO Pawan Kumar helps inspire and encourage everyone associated with the company to maintain high quality data and help clients in every way possible to achieve success. All data presented in the reports we publish are drawn from primary interviews with senior managers of large companies in the relevant field. Our secondary data sourcing methodology includes extensive online and offline research and discussions with knowledgeable industry professionals and analysts.

CONTACT: David Correa 5933 NE Win Sivers Drive #205, Portland, OR 97220 United States USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022 UK: +44-845-528-1300 Hong Kong: +852-301-84916 India (Pune): +91-20-66346060 Fax: +1(855)550-5975 help@alliedmarketresearch.com

Leave a Comment